Selank
Selank is a synthetic heptapeptide analog of the naturally occurring immune peptide tuftsin, developed by the Russian Academy of Sciences.
View researchSelank is a synthetic heptapeptide analog of the naturally occurring immune peptide tuftsin, developed by the Russian Academy of Sciences.
View researchSemaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist FDA-approved for type 2 diabetes management (as Ozempic injectable or Rybelsus oral) and chronic weight management (as…
View researchSemax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH) fragment 4-10, extensively studied for its nootropic, neuroprotective, and neurorestorative properties.
View researchSermorelin acetate is a 29-amino acid synthetic analog of human growth hormone-releasing hormone (GHRH) originally FDA-approved in 1997 for pediatric growth hormone deficiency.
View researchSLU-PP-332 is a groundbreaking synthetic small-molecule compound developed at Saint Louis University that functions as a pan-estrogen-related receptor (ERR) agonist with preferential activity at ERRα.
View researchSNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide developed as a topical alternative to botulinum toxin for reducing dynamic facial wrinkles.
View researchSS-31, also known as Elamipretide or Bendavia, is a small aromatic-cationic tetrapeptide that selectively targets mitochondria.
View researchSurvodutide (BI 456906) is an investigational dual glucagon receptor (GCGR) and GLP-1 receptor (GLP-1R) agonist designed for once-weekly subcutaneous administration.
View researchTB-500 is a synthetic 7-amino acid fragment (Ac-LKKTETQ) corresponding to the active actin-binding region (positions 17-23) of thymosin beta-4.
View researchTesamorelin is an FDA-approved synthetic growth hormone-releasing hormone (GHRH) analog designed for treating HIV-associated lipodystrophy.
View researchTesofensine (NS2330) is a triple monoamine reuptake inhibitor that blocks the reuptake of dopamine, norepinephrine, and serotonin.
View researchTestagen (KEDG, Lys-Glu-Asp-Gly) is a synthetic tetrapeptide bioregulator developed by Russian scientist Vladimir Khavinson and his team at the St.
View research